Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 10542
MIM: 608521
HGNC: 17955
Ensembl: ENSG00000134248
Variants:
dbSNP: 10542
ClinVar: 10542
TCGA: ENSG00000134248
COSMIC: LAMTOR5
RNA/Proteins
Expression (GTEx)
Pathways
Protein levels (Protein atlas)
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 38577934 | 2024 | Research progress on oncoprotein hepatitis B X‑interacting protein (Review). | 0 |
| 38639386 | 2024 | Defective Lamtor5 Leads to Autoimmunity by Deregulating v-ATPase and Lysosomal Acidification. | 1 |
| 38577934 | 2024 | Research progress on oncoprotein hepatitis B X‑interacting protein (Review). | 0 |
| 38639386 | 2024 | Defective Lamtor5 Leads to Autoimmunity by Deregulating v-ATPase and Lysosomal Acidification. | 1 |
| 33824459 | 2022 | The modulation of PD-L1 induced by the oncogenic HBXIP for breast cancer growth. | 7 |
| 35093383 | 2022 | HBXIP is a novel regulator of the unfolded protein response that sustains tamoxifen resistance in ER+ breast cancer. | 3 |
| 33824459 | 2022 | The modulation of PD-L1 induced by the oncogenic HBXIP for breast cancer growth. | 7 |
| 35093383 | 2022 | HBXIP is a novel regulator of the unfolded protein response that sustains tamoxifen resistance in ER+ breast cancer. | 3 |
| 33305825 | 2021 | HBXIP drives metabolic reprogramming in hepatocellular carcinoma cells via METTL3-mediated m6A modification of HIF-1α. | 52 |
| 33628588 | 2021 | Oncoprotein HBXIP promotes tumorigenesis through MAPK/ERK pathway activation in non-small cell lung cancer. | 3 |
| 34216584 | 2021 | HBXIP accelerates glycolysis and promotes cancer angiogenesis via AKT/mTOR pathway in bladder cancer. | 8 |
| 34374893 | 2021 | LAMTOR5 expression level is a biomarker for colorectal cancer and lncRNA LAMTOR5-AS1 predicting miRNA sponging effect. | 6 |
| 34452886 | 2021 | Down-Regulation of HBXIP Inhibits Non-Small Cell Lung Cancer Growth and Enhances the Anti-Tumor Immunity of Mice by Reducing NRP-1. | 1 |
| 34730200 | 2021 | High HBXIP expression is related to poor prognosis in HCC by extensive database interrogation. | 1 |
| 33305825 | 2021 | HBXIP drives metabolic reprogramming in hepatocellular carcinoma cells via METTL3-mediated m6A modification of HIF-1α. | 52 |
Citation
Dessen P
LAMTOR5 (late endosomal/lysosomal adaptor, MAPK and MTOR activator 5)
Atlas Genet Cytogenet Oncol Haematol. 2012-10-01
Online version: http://atlasgeneticsoncology.org/gene/47590/lamtor5
